Left atrial phasic volumes and functions changes in asymptomatic patients with sarcoidosis: evaluation by three-dimensional echocardiography

H Solmaz, O Ozdogan - Acta Cardiologica, 2022 - Taylor & Francis
Background Cardiac involvement is the leading cause of morbidity and death in patients
with sarcoidosis. However, many patients remain asymptomatic until the late-stage. In this …

Prognostic Implications of Cardiac Geometry in Cirrhosis: Findings From a Large Cohort

Y Jia, L Liu, Y Zhou, Y Yao, Y Cheng… - Liver …, 2025 - Wiley Online Library
ABSTRACT Background and Aims Cirrhosis is characterised by hyperdynamic circulation,
which contributes to cirrhotic cardiomyopathy (CCM). However, the expert consensus on …

The effect of empagliflozin on P wave peak time and other P wave parameters in patients with diabetes mellitus

B Aslan, A Akyüz, F Işık, B Boyraz, Ü İnci… - Pacing and Clinical …, 2022 - Wiley Online Library
Background Empagliflozin is a selective SGLT2 inhibitor and provides a significant reduction
in hospitalizations in heart failure patients and a reduction in combined cardiovascular …

Can Multi-organ Sonographic Parameters Predict Mortality in Patients With Acute Kidney Injury?

MA Aslaner, MN Cerit, Ş Esen - Journal of Diagnostic …, 2024 - journals.sagepub.com
Objective: This study aimed to investigate sonographic parameters that could predict 1-
month mortality in patients with acute kidney injury (AKI). Materials and Methods: This study …

[HTML][HTML] Cardiomiopatía cirrótica–¿ Realidad clínica o simple curiosidad académica? Revisión. Parte 2: ECG, pruebas funcionales, estudios con imágenes …

HR Ramos, MH Altieri - Revista de la Facultad de Ciencias …, 2024 - pmc.ncbi.nlm.nih.gov
El diagnóstico de Cardiomiopatía Cirrótica está basado en la presencia de cirrosis hepática
avanzada con alteraciones de la función cardíaca sin cardiopatía pre-existente, pero en …